Il-2 receptor antagonist which is an antibody that specifically binds the p55 subunit of the human interleukin-2 receptor for use in treating a human subject with multiple sclerosis

摘要

A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to the subject a therapeutically effective amount of an IL-21 receptor antagonist, wherein the subject has failed to respond treatment with beta interferon, thereby treating the subject.